Testing and updates: How to track your health metrics over time

You should track your health metrics over time with daily wearable and home readings plus at least two lab updates a year, especially if testosterone is below 350 ng/dL or free testosterone is below 100 pg/mL with symptoms. The most useful men’s health monitoring plan combines fast moving signals like sleep, resting heart rate, and blood pressure with slower biomarkers such as testosterone, lipids, CBC, and PSA after age 40.

Key takeaways

• Hypogonadism is not diagnosed by one low number. It requires persistent symptoms plus properly timed biochemical evidence, and LH and FSH are essential to classify primary versus secondary disease.^{[1] [2]}
• Veedma uses morning draws from 07:00 to 11:00 and decision thresholds of total testosterone 350 ng/dL and free testosterone 100 pg/mL when symptoms persist, with free testosterone measured directly by equilibrium dialysis and LC MS/MS.
• A 1 MET higher cardiorespiratory fitness level is associated with about a 13 percent lower risk of all cause mortality and a 15 percent lower risk of cardiovascular events in a large meta analysis.^[6]
• In the TRAVERSE trial, testosterone therapy was noninferior to placebo for major cardiovascular events in 5,246 men followed for a mean of 33 months, while elevated hematocrit remained a key monitoring issue.^[5]
• In one company survey of more than 700 men, nearly three quarters said they actively track health data, nearly 80 percent tracked lab results, 48 percent tracked sleep and recovery, and 45 percent tracked calories, macros, or micronutrients.

Why time series data beats a single snapshot

Biomarker tracking works because the male body does not change on one timetable. Wearables and home tools catch fast moving signals such as resting heart rate, training load, sleep duration, and blood pressure, while lab updates reveal slower shifts in testosterone, cholesterol, blood counts, liver enzymes, kidney function, and PSA. According to the Endocrine Society and American Urological Association, even testosterone should be interpreted as repeat morning testing, not as a one off result pulled out of context.^{[1] [2] [3]}

Fitness data can be especially useful when it is trended instead of admired. A 2009 JAMA meta analysis found that each 1 MET increase in cardiorespiratory fitness was tied to a roughly 13 percent lower risk of all cause mortality and a 15 percent lower risk of cardiovascular events.^[6] That helps explain why so many men now watch estimated VO2 max, pace at a given heart rate, or power output over months, not days. In the midlife male optimization crowd, that pattern is already common. In a company survey of more than 700 men, 41 percent said they “keep an eye” on metrics regularly, 22 percent said they were deeply invested, and only 25 percent said they tracked none at all.

Sleep is a good example of how lab updates and wearables talk to each other. A widely cited JAMA study found that restricting healthy young men to 5 hours of sleep per night for 1 week reduced daytime testosterone by 10 to 15 percent.^[7] If your watch shows a run of short nights and your morning lab testing looks worse than usual, that connection may be physiology, not bad luck.

How to build a men’s health monitoring system

A useful system starts with a clean baseline, then repeats the right measurements at the right intervals.

Start with a real baseline

Morning health testing is the foundation because testosterone follows a diurnal rhythm and assay quality matters. The HPG axis, the brain to testes signaling loop that controls testosterone production, cannot be interpreted correctly without total testosterone, free testosterone, LH, and FSH measured together, ideally between 07:00 and 11:00 on more than one occasion when symptoms persist.^{[1] [2]}

Most commercial labs rely heavily on immunoassays, which can be less reliable in borderline cases, while direct free testosterone measured by equilibrium dialysis with LC MS/MS is considered a stronger analytic approach.^[3] At Veedma, the core panel also includes estradiol, CBC, comprehensive metabolic panel, and PSA after age 40, with lipids, prolactin, TSH, and vitamin D added when indicated. Because free testosterone is measured directly, Veedma does not need a separate SHBG calculation to estimate it.

Use wearables for trend lines, not verdicts

Wearables are best at repeated observation, not diagnosis. A 2015 systematic review found that consumer activity trackers were reasonably valid for step counts and some heart rate measures, but accuracy varied for energy expenditure and more advanced outputs.^[8]

HRV, or heart rate variability, is the beat to beat variation between heartbeats and a rough recovery signal, not a disease label. VO2 max estimates from watches can also be directionally useful, but actual cardiorespiratory fitness measured in the lab remains the stronger predictor of health outcomes.^{[6] [8]}

Repeat each metric on the right schedule

Repeated measurements beat random measurements because biology is noisy. According to a systematic review in Annals of Internal Medicine, self measured blood pressure improves hypertension management, which is why home cuffs are more useful than occasional readings at a pharmacy kiosk or after a rushed commute.^[9]

For most men, the best cadence is daily for sleep and resting heart rate, weekly for body weight, waist size, and home blood pressure, and twice yearly for a 40 plus biomarker lab panel. If you change medication, add supplements, start Enclomiphene, begin TRT, or make a major diet and training change, a targeted recheck in 8 to 12 weeks is usually more informative than waiting a full year.^{[1] [2] [9]}

Know the fork in the road for low testosterone

Low testosterone alone is not a diagnosis. Major guidelines state that male hypogonadism requires both persistent symptoms and biochemical evidence on properly timed testing, which is why fatigue by itself and one low lab value by itself are both incomplete.^{[1] [2]}

High LH with low testosterone points toward primary hypogonadism, meaning the testes are failing to respond. Low or normal LH with low testosterone points toward secondary or functional hypogonadism, where the signaling pathway is suppressed but still intact. At Veedma, men with symptoms plus total testosterone below 350 ng/dL or free testosterone below 100 pg/mL are evaluated carefully, and men with low or normal LH, especially below 8 mIU/mL, are often considered for Enclomiphene first because it can stimulate natural testosterone production while preserving spermatogenesis and testicular function. TRT is generally reserved for primary hypogonadism or secondary disease that does not respond, and CBC monitoring matters because elevated hematocrit is the most common adverse effect.^{[1] [2] [5]}

What better tracking can uncover

Good tracking can u